EODData

MEMBERSHIP REGISTER LOG IN

FRA, PQ6A: STARPHARMA HLDG.SP.ADR/10

07 Nov 2025
LAST:

1.830

CHANGE:
 0.09		OPEN:
1.830		HIGH:
1.830		ASK:
0.000		VOLUME:
0
CHG(%):
4.69		PREV:
1.920		LOW:
1.830		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 251.8301.8301.8301.8300
06 Nov 251.9201.9201.9201.9200
05 Nov 251.8201.8201.8201.8200
04 Nov 251.8601.8601.8601.8600
03 Nov 251.9001.9001.9001.9000
31 Oct 251.9201.9201.9201.9200
30 Oct 251.9601.9601.9601.9600
29 Oct 251.9801.9801.9801.9800
28 Oct 251.7901.7901.7901.7900
27 Oct 251.8101.8101.8101.8100

COMPANY PROFILE

Name:STARPHARMA HLDG.SP.ADR/10
About:Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It is also involved in the development of a dendrimer-enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; SPL7013 for vaginal gel, is a treatment of bacterial vaginosis and prevention of recurrent BV, and an antiviral condom; and DEP HER2 radiodiagnostic. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma's dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:4-6 Southampton Crescent, Abbotsford, VIC, Australia, 3067
Website:https://starpharma.com
ISIN:US8555631022

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-7.78 
Price to Sales:14.04 
Price to Book:42.22 
Profit Margin:-1.71 
Operating Margin:-1.34 
Return on Assets:-0.20 
Return on Equity:-0.42 
Revenue:3.32M 
Shares:41.82M 
Market Cap:76.54M 

TECHNICAL INDICATORS

MA5:1.872.0%
MA10:1.882.7%
MA20:1.717.3%
MA50:1.2843.2%
MA100:0.90104.3%
MA200:0.69163.3%
STO9:21.05
STO14:61.54
RSI14:67.82 
WPR14:-38.46
MTM14:0.24
ROC14:0.15 
ATR:0.06 
Week High:1.924.9%
Week Low:1.820.5%
Month High:1.988.2%
Month Low:1.36163.3%
Year High:1.988.2%
Year Low:0.39365.6%
Volatility:48.90